Essity Aktiebolag (ESSITY.A) Price & Analysis

Compare

0 Followers

ESSITY.A Stock Chart & Stats

kr261.00

-kr8.50(-2.81%)

At close: Mar 06 4:00 PM EST

kr261.00

-kr8.50(-2.81%)

Day’s Range― - ―

52-Week Rangekr237.00 - kr312.00

Previous CloseN/A

Volume3.03K

Average Volume (3M)25.39K

Market Cap

kr194.63B

Enterprise Valuekr224.98B

Total Cash (Recent Filing)kr9.75B

Total Debt (Recent Filing)kr38.63B

Price to Earnings (P/E)15.4

Beta0.22

Next Earnings

Apr 23, 2026

EPS Estimate

4.51

Next Dividend Ex-DateN/A

Dividend Yield3.14%

Share Statistics

EPS (TTM)4.69

Shares Outstanding57,200,657

10 Day Avg. Volume13,063

30 Day Avg. Volume25,387

Financial Highlights & Ratios

PEG Ratio-0.38

Price to Book (P/B)2.13

Price to Sales (P/S)1.32

P/FCF Ratio21.83

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Balance Sheet StrengthReported zero debt in 2025 signals a materially stronger balance sheet and greater financial flexibility. This durable improvement reduces refinancing risk, supports sustained dividends, buybacks and M&A, and provides a structural buffer to invest in growth or weather downturns without immediate liquidity pressure.

Margin Recovery And ProfitabilityMaterial margin expansion reflects sustained pricing power and improved cost control, including realized COGS tailwinds. Higher and more stable gross and operating margins enhance long-term earnings power and cash generation, enabling reinvestment and payout policies while improving return on capital across business cycles.

Market Position & Strategic ExpansionThe Edgewell acquisition and sustained Medical momentum broaden U.S. scale and high-yield category exposure. Doubling U.S. personal care sales and consistent Medical growth create durable market share, better shelf presence and distribution leverage, improving revenue mix and long-term competitive positioning.

Bears Say

Top-line ContractionMulti-year revenue decline reduces operating leverage and limits sustainable growth potential. Persistent top-line contraction forces management to rely on margin fixes or M&A for earnings growth, increases pressure to reinvest in A&P to restore volumes, and raises the bar for durable organic recovery.

Moderate Cash ConversionFCF at roughly half of net income indicates that reported profits do not fully convert into cash, likely due to working-capital swings or non-cash items. This persistent conversion gap constrains ability to self-fund capex, acquisitions and payouts without drawing on reserves or increasing leverage over time.

Execution & Volume RisksLost private-label contracts and category volume weakness reflect structural competitive pressure on volumes and mix. Coupled with limited realized SG&A savings and upfront restructuring costs, this raises execution risk: restoring volumes may require sustained reinvestment, margin phasing, and effective cost-program delivery.

ESSITY.A FAQ

What was Essity Aktiebolag ’s price range in the past 12 months?

Essity Aktiebolag lowest stock price was kr237.00 and its highest was kr312.00 in the past 12 months.

What is Essity Aktiebolag ’s market cap?

Essity Aktiebolag ’s market cap is kr194.63B.

When is Essity Aktiebolag ’s upcoming earnings report date?

Essity Aktiebolag ’s upcoming earnings report date is Apr 23, 2026 which is in 61 days.

How were Essity Aktiebolag ’s earnings last quarter?

Essity Aktiebolag released its earnings results on Jan 22, 2026. The company reported kr4.69 earnings per share for the quarter, missing the consensus estimate of kr4.84 by -kr0.15.

Is Essity Aktiebolag overvalued?

According to Wall Street analysts Essity Aktiebolag ’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Essity Aktiebolag pay dividends?

Essity Aktiebolag pays a Annually dividend of kr8.25 which represents an annual dividend yield of 3.14%. See more information on Essity Aktiebolag dividends here

What is Essity Aktiebolag ’s EPS estimate?

Essity Aktiebolag ’s EPS estimate is 4.51.

How many shares outstanding does Essity Aktiebolag have?

Essity Aktiebolag has 57,200,657 shares outstanding.

What happened to Essity Aktiebolag ’s price movement after its last earnings report?

Essity Aktiebolag reported an EPS of kr4.69 in its last earnings report, missing expectations of kr4.84. Following the earnings report the stock price went down -7.024%.

Which hedge fund is a major shareholder of Essity Aktiebolag ?

Currently, no hedge funds are holding shares in SE:ESSITY.A

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Essity Aktiebolag

Essity AB (publ) develops, produces, and sells hygiene and health products and services worldwide. It offers health and medical products, including incontinence products, wound care, compression therapy, orthopedics, skincare products, and digital solutions with sensor technology. It operates in Personal Care, Consumer Tissue, Professional Hygiene, and Other segments. The company also provides consumer goods, such as incontinence products, pads, diapers, wet wipes, skincare products, intimate soaps, washable absorbent underwear, menstrual cups, toilet papers, household towels, handkerchiefs, facial tissues, and napkins; and professional hygiene products that consist of toilet papers, paper hand towels, napkins, hand soaps, hand lotions, hand sanitizers, dispensers, and cleaning and wiping products. In addition, it offers digital solutions, such as Internet of Things sensor technology enabling data-driven cleaning, as well as related service and maintenance to companies and office buildings, universities, healthcare facilities, industries, restaurants, hotels, stadiums, and other public venues. The company markets its health and medical products under the TENA, Leukoplast, Cutimed, JOBST, Actimove, and Delta-Castbrands brands through pharmacies, medical devices stores, hospitals, distributors, and care institutions, as well as e-commerce; consumer goods products under the Libero, Libresse, Nosotras, Saba, TOM Organic, Lotus, Regio, Tempo, and Vinda brands through retail trade and online; and professional hygiene products under the TORK brand through distributors and online. It serves in Europe, North America, Latin America, Asia, and internationally. Essity AB (publ) was founded in 1849 and is headquartered in Stockholm, Sweden.